Thomas Williamson

CCO at Bio Tissue

Tom Williamson is a top producing commercial executive with both large company and start-up experience. Under Tom’s leadership, the Stryker Interventional Spine sales team became a revenue growth leader and established a strong foothold in the competitive vertebral compression fracture market. He then joined Entellus Medical where his last role was VP, Commercial Operations. He helped Entellus grow to over $100M in sales and was integral in their acquisition of Spirox and the final exit of Entellus to Stryker for $662M. Tom holds a Bachelor of Science degree in Chemical Engineering from Louisiana State University and has completed extensive leadership training at Harvard University.

Links

Previous companies

Stryker logo
BioStable logo

Org chart

Sign up to view 1 direct report

Get started